New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 15, 2013
06:31 EDTBLUEBluebird Bio initiated with a Buy at Canaccord
Target $45.
News For BLUE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2015
07:31 EDTBLUELeerink to hold a roundtable
Subscribe for More Information
September 29, 2015
08:33 EDTBLUEAlexandria Real Estate announces bluebird bio executed lease
Alexandria Real Estate (ARE) Equities announced that bluebird bio (BLUE) executed a 10-year lease for approximately 253,000 rentable square feet at 60 Binney Street at the Alexandria Center at Kendall Square campus. The lease encompasses the entire 60 Binney Street building with the exception of a ground-floor retail suite. With the relocation of its headquarters to 60 Binney Street, bluebird bio, a clinical-stage biotechnology company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies, will be expanding its presence in Cambridge to support the company's continued growth. The 60 Binney Street project, which is targeting LEED Gold Certification, is expected to be delivered in late 2016.
September 25, 2015
11:35 EDTBLUEbluebird bio management to meet with Maxim
5:30 pm Cocktails, followed by 6pm Group dinner with management will be held in New York on September 30 hosted by Maxim.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use